ZYMUTEST HIA IgGAM

In US: 510(k) Cleared for In Vitro Diagnostic Use for Plasma only.
In EU: This Product is CE Marked.
Health Canada Licensed.
ZYMUTEST HIA IgGAM
Code: ARK040D
Manufacturer’s Part Number: RK040D
Shipping Weight: 2.00 pounds
Quantity in Basket: None
Price: $615.00
Quantity:

Product Description

Enzyme immuno-assay designed for measuring globally all heparin-dependent antibodies, whether the isotype is: IgG, IgM and IgA, in human plasma or serum, or in any biological fluid where these antibodies must be measured. This assay is proposed as screening, as an early identification of heparin treated patients presenting a risk to develop HIT or HITT. This assay measures the whole of antibodies. It offers the highest sensitivity as all isotypes are detected. It is the preferred assay when an early detection of heparin dependent antibodies is required for assessing the development risk of HIT/HITT.

Product Video

Information


SKU ID# Packaging Website Links
ARK040D Kit of 96 tests www.hit-assay.com
www.zymutest.com
Resources-HIT-ASSAY
 
Assay Characteristics Kit Components Applications
Total Assay Time: 2h 15 min.
Cut Off: A450 ≥ 0.50
Dynamic Range: A450 up to 3.0
Intra-Assay CV: 4 to 6%
Inter-Assay CV: 5 to 8%
 
Micro ELISA Plate (12 strips of 8 wells)
2x HIA Sample Diluent.
3x HIA IgGAM Positive Control.
3x Negative Control.
3x Platelet Lysate.
3x Anti-IgG (Fcγ)-IgM (µ)-IgA(α)-HRP IC
1x Conjugate Diluent.
1x Wash Solution.
1x TMB.
1x 0.45M Sulfuric Acid.

Assessment of the risk to develop HIT/HITT, in patients treated with heparins (Unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT.

Clinical suspicion of HIT during heparin therapy.

Streamline Laboratory Procedures

Ready-to-use reagents and buffers, from Medicago AB. Available in tablets and pouches.
 

Downloads

Package Inserts MSDS Tech Specs Adaptations
ZYM. HIA IgGAM - CE
ZYM. HIA IgGAM - 501(k)
ZYM. HIA IgGAM ZYM. HIA IgGAM NA